Kan SL, Yang B, Ning GZ, Chen LX, Li YL, Gao SJ, Chen XY, Sun JC, Feng SQ (2015) Nonsteroidal anti-inflammatory drugs as prophylaxis for heterotopic ossification after total hip arthroplasty: a systematic review and meta-analysis. Medicine (Baltimore) 94(18):e828. https://doi.org/10.1097/MD.0000000000000828

Article  Google Scholar 

Kienapfel H, Koller M, Wust A, Sprey C, Merte H, Engenhart-Cabillic R, Griss P (1999) Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication. Arch Orthop Trauma Surg 119(5–6):296–302. https://doi.org/10.1007/s004020050414

CAS  Article  PubMed  Google Scholar 

Nilsson OS, Persson PE (1999) Heterotopic bone formation after joint replacement. Curr Opin Rheumatol 11(2):127–131. https://doi.org/10.1097/00002281-199903000-00008

CAS  Article  PubMed  Google Scholar 

Winkler S, Springorum HR, Vaitl T, Handel M, Barta S, Kehl V, Craiovan B, Grifka J (2016) Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac. Int Orthop 40(4):673–680. https://doi.org/10.1007/s00264-015-3077-z

Article  PubMed  Google Scholar 

Xue D, Zheng Q, Li H, Qian S, Zhang B, Pan Z (2011) Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials. Int Orthop 35(1):3–8. https://doi.org/10.1007/s00264-009-0886-y

Article  PubMed  Google Scholar 

Seegenschmiedt MH, Goldmann AR, Wolfel R, Hohmann D, Beck H, Sauer R (1993) Prevention of heterotopic ossification (HO) after total hip replacement: randomized high versus low dose radiotherapy. Radiother Oncol 26(3):271–274. https://doi.org/10.1016/0167-8140(93)90270-i

CAS  Article  PubMed  Google Scholar 

Grohs JG, Schmidt M, Wanivenhaus A (2007) Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop 78(1):95–98. https://doi.org/10.1080/17453670610013484

Article  PubMed  Google Scholar 

Thomas BJ, Amstutz HC (1985) Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty. J Bone Jt Surg Am 67(3):400–403

CAS  Article  Google Scholar 

van der Heide HJ, Spruit M, Slappendel R, Klooster N, van Limbeek J (2004) Prophylaxis for heterotopic ossification after primary total hip arthroplasty. A cohort study between indomethacin and meloxicam. Acta Orthop Belg 70(3):240–246

PubMed  Google Scholar 

Ghlichloo I, Gerriets V (2021) Nonsteroidal anti-inflammatory drugs (NSAIDs). StatPearls, Treasure Island

Tozun R, Pinar H, Yesiller E, Hamzaoglu A (1992) Indomethacin for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 7(1):57–61. https://doi.org/10.1016/0883-5403(92)90033-m

CAS  Article  PubMed  Google Scholar 

Kjaersgaard-Andersen P, Nafei A, Teichert G, Kristensen O, Schmidt SA, Keller J, Lucht U (1993) Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties. Acta Orthop Scand 64(6):639–642. https://doi.org/10.3109/17453679308994587

CAS  Article  PubMed  Google Scholar 

Schmidt SA, Kjaersgaard-Andersen P, Pedersen NW, Kristensen SS, Pedersen P, Nielsen JB (1988) The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial. J Bone Jt Surg Am 70(6):834–838

CAS  Article  Google Scholar 

Vielpeau C, Joubert JM, Hulet C (1999) Naproxen in the prevention of heterotopic ossification after total hip replacement. Clin Orthop Relat Res 369:279–288. https://doi.org/10.1097/00003086-199912000-00029

Article  Google Scholar 

Jockheck M, Willms R, Volkmann R, Sell S, Weller S, Kusswetter W (1998) Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac. Arch Orthop Trauma Surg 117(6–7):337–340. https://doi.org/10.1007/s004020050261

CAS  Article  PubMed  Google Scholar 

Persson PE, Sodemann B, Nilsson OS (1998) Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time. Acta Orthop Scand 69(2):111–115. https://doi.org/10.3109/17453679809117608

CAS  Article  PubMed  Google Scholar 

Barthel T, Baumann B, Noth U, Eulert J (2002) Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand 73(6):611–614. https://doi.org/10.1080/000164702321039543

Article  PubMed  Google Scholar 

Laine L (2003) Gastrointestinal effects of NSAIDs and coxibs. J Pain Symptom Manage 25(2 Suppl):S32–40. https://doi.org/10.1016/s0885-3924(02)00629-2

Rahme E, Barkun AN, Adam V, Bardou M (2004) Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs. Drug Saf 27(13):1019–1042. https://doi.org/10.2165/00002018-200427130-00004

Article  PubMed  Google Scholar 

Romano CL, Duci D, Romano D, Mazza M, Meani E (2004) Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 19(1):14–18. https://doi.org/10.1016/s0883-5403(03)00279-1

Article  PubMed  Google Scholar 

Lavernia CJ, Contreras JS, Villa JM, Rossi MD (2014) Celecoxib and heterotopic bone formation after total hip arthroplasty. J Arthroplasty 29(2):390–392. https://doi.org/10.1016/j.arth.2013.06.039

Article  PubMed  Google Scholar 

Oni JK, Pinero JR, Saltzman BM, Jaffe FF (2014) Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study. Hip Int 24(3):256–262. https://doi.org/10.5301/hipint.5000109

Article  PubMed  Google Scholar 

Brunnekreef JJ, Hoogervorst P, Ploegmakers MJ, Rijnen WH, Schreurs BW (2013) Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty? Int Orthop 37(4):583–587. https://doi.org/10.1007/s00264-013-1781-0

Article  PubMed  PubMed Central  Google Scholar 

Xu BG, Xue DT, Wang XH, Yan SG (2014) Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials. Zhongguo Gu Shang 27(7):609–614

PubMed  Google Scholar 

Saudan M, Saudan P, Perneger T, Riand N, Keller A, Hoffmeyer P (2007) Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial. J Bone Jt Surg Br 89(2):155–159. https://doi.org/10.1302/0301-620X.89B2.17747

CAS  Article  Google Scholar 

Barbato M, D’Angelo E, Di Loreto G, Menna A, Di Francesco A, Salini V, Zoppi U, Cavasinni L, La Floresta P, Romano CL (2012) Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey. J Orthop Traumatol 13(2):63–67. https://doi.org/10.1007/s10195-012-0180-4

Article  PubMed  PubMed Central  Google Scholar 

Legosz P, Otworowski M, Sibilska A, Starszak K, Kotrych D, Kwapisz A, Synder M (2019) Heterotopic ossification: a challenging complication of total hip arthroplasty: risk factors, diagnosis, prophylaxis, and treatment. Biomed Res Int 2019:3860142. https://doi.org/10.1155/2019/3860142

CAS  Article  PubMed  PubMed Central  Google Scholar 

Whelton A (2002) COX-2-specific inhibitors and the kidney: effect on hypertension and oedema. J Hypertens Suppl 20(6):S31-35

CAS  PubMed  Google Scholar 

Jones P, Lamdin R (2010) Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis. Clin Drug Investig 30(7):419–437. https://doi.org/10.2165/11533350-000000000-00000

CAS  Article  PubMed  Google Scholar 

Howick JCI, Glasziou P, Greenhalgh T, Carl Heneghan, Liberati A, Moschetti I, Phillips B, Thornton H, Goddard O, Hodgkinson M (2011) The 2011 Oxford CEBM Levels of Evidence. Oxford Centre for Evidence-Based Medicine, Oxford. Available at https://www.cebmnet/indexaspx?o=5653.

van der Heide HJ, Koorevaar RC, Lemmens JA, van Kampen A, Schreurs BW (2007) Rofecoxib inhibits heterotopic ossification after total hip arthroplasty. Arch Orthop Trauma Surg 127(7):557–561. https://doi.org/10.1007/s00402-006-0243-1

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

Article  PubMed  PubMed Central  Google Scholar 

Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr (1973) Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Jt Surg Am 55(8):1629–1632

CAS  Article  Google Scholar 

Legenstein R, Bosch P, Ungersbock A (2003) Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty. Arch Orthop Trauma Surg 123(2–3):91–94. https://doi.org/10.1007/s00402-003-0487-y

Article  PubMed  Google Scholar 

Reis HJ, Kusswetter W, Schellinger T (1992) The suppression of heterotopic ossification after total hip arthroplasty. Int Orthop 16(2):140–145. https://doi.org/10.1007/BF00180205

CAS  Article  PubMed  Google Scholar 

van der Heide HJ, Rijnberg WJ, Van Sorge A, Van Kampen A, Schreurs BW (2007) Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty. Acta Orthop 78(1):90–94. https://doi.org/10.1080/17453670610013475

Article  PubMed  Google Scholar 

Elmstedt E, Lindholm TS, Nilsson OS, Tornkvist H (1985) Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand 56(1):25–27. https://doi.org/10.3109/17453678508992973

CAS  Article  PubMed  Google Scholar 

Sodemann B, Persson PE, Nilsson OS (1988) Prevention of heterotopic ossification by nonsteroid antiinflammatory drugs after total hip arthroplasty. Clin Orthop Relat Res 237:158–163

Google Scholar 

Pritchett JW (1995) Ketorolac prophylaxis against heterotopic ossification after hip replacement. Clin Orthop Relat Res 314:162–165

Google Scholar 

Migliorini F, Trivellas A, Eschweiler J, Driessen A, Tingart M, Maffulli N (2021) NSAIDs for prophylaxis for heterotopic ossification after total hip arthroplasty: a Bayesian network meta-analysis. Calcif Tissue Int 108(2):196–206. https://doi.org/10.1007/s00223-020-00763-7

CAS  Article  PubMed